Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse

Brain Research Reviews

Volumn 26, Issue 1, 1998, Pages 29-42

  Vela, José Miguel ^a   González, Berta ^a   Castellano, Bernardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Astrocyte; Glial development; Hypomyelination; Jimpy; Microglia; Neuroglia; Oligodendrocyte; PLP

Indexed keywords

GLIA; MOUSE; MYELIN DEFICIENCY; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SEX CHROMOSOMAL INHERITANCE;

ANIMALS; DEMYELINATING DISEASES; MICE; MICE, JIMPY; MUTATION; MYELIN SHEATH; NEUROGLIA;

EID: 0345367980     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00055-6     Document Type: Review

References (180)

1. Apasov S., Redegeld F., Sitkovsky M. Cell-mediated cytotoxicity: contact and secreted factors. Curr. Opin. Immunol. 5:1993;404-410.
2. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
3. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 118:1993;283-295.
4. Bartlett W.P., Skoff R.P. Expression of the jimpy gene in the spinal cords of heterozygous female mice: 2. Oligodendroglial and endothelial cell hyperplasia. Dev. Brain Res. 47:1989;1-11.
5. Bartlett W.P., Skoff R.P. Expression of the jimpy gene in the spinal cords of heterozygous female mice: I. An early deficit followed by compensation. J. Neurosci. 6:1986;2802-2812.
6. Bartlett W.P., Knapp P.E., Skoff R.P. Glial-conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: production of myelin antigens and membranes. Glia. 1:1988;253-259.
7. Benjamins J.A., Skoff R.P., Beyer K. Biochemical expression of mosaicism in female mice heterozygous for the jimpy gene. J. Neurochem. 42:1984;487-492.
8. Benjamins J.A., Studzinski D.M., Skoff R.P. Biochemical correlates of myelination in brain and spinal cord of mice heterozygous for the jimpy gene. J. Neurochem. 47:1986;1857-1863.
9. E.N. Benveniste, Cytokine production, in: H. Kettenmann, B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 700-713.
10. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol. 263:1992;C1-C16.
11. Best T.T., Skoff R.P., Bartlett W.P. Astroglial plasticity in hemizygous and heterozygous jimpy mice. Int. J. Dev. Neurosci. 6:1988;39-57.
12. Bignami A., Dahl D. Glial fibrillary acidic protein in mutant mice with deficiency of myelination: quaking and jimpy. Acta Neuropathol. 28:1974;269-272.
13. msd and comparison with jp and qk on their present genetic backgrounds. Brain Res. 194:1980;325-338.
14. msd, and qk axons by normal glia in vitro: ultrastructural and autoradiographic evidence. Brain Res. 268:1983;255-266.
15. *jimpy double mutant mice: additional evidence for independence of primary deficits in jimpy. Mol. Brain Res. 7:1990;189-198.
16. Billings-Gagliardi S., Wolf M.K., Kirschner D.A., Kerner A.L. Shiverer jimpy double mutant mice: II. Morphological evidence supports reciprocal intergenic suppression. Brain Res. 374:1986;54-62.
17. Black J.A., Fields R.D., Waxman S.G. Macromolecular structure of axonal membrane in the optic nerve of the jimpy mouse. J. Neuropathol. Exp. Neurol. 47:1988;588-598.
18. Boison D., Stoffel W. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11709-11713.
19. Boison D., Stoffel W. Myelin-deficient rat: a point mutation in exon III (A-C, Thr75-Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. EMBO J. 8:1989;3295-3302.
20. Boison D., Bussow H., D'Urso D., Muller H.W., Stoffel W. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J. Neurosci. 15:1995;5502-5513.
21. Bolivar V.J., Brown R.E. The ontogeny of ultrasonic vocalizations and other behaviors in male jimpy (jp/Y) mice and their normal male littermates. Dev. Psychobiol. 27:1994;101-110.
22. Bongarzone E.R., Foster L.M., Byravan S., Schonmann V., Campagnoni A.T. Temperature-dependent regulation of PLP/DM20 and CNP gene expression in two conditionally-immortalized jimpy oligodendrocyte cell lines. Neurochem. Res. 22:1997;363-372.
23. Cambi F., Tang X.M., Cordray P., Fain P.R., Keppen L.D., Barker D.F. Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology. 46:1996;1112-1117.
24. Cammer W., Sacchi R., Kahn S., Sapirstein V. Oligodendroglial structures and distribution shown by carbonic anhydrase immunostaining in the spinal cords of developing normal and shiverer mice. J. Neurosci. Res. 14:1985;303-316.
25. Campagnoni A.T., Macklin W.B. Cellular and molecular aspects of myelin protein gene expression. Mol. Neurobiol. 2:1988;41-89.
26. Campagnoni A.T. Molecular biology of myelin proteins from the central nervous system. J. Neurochem. 51:1988;1-14.
27. Carango P., Funanage V.L., Quiros R.E., Debruyn C.S., Marks H.G. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease. Ann. Neurol. 38:1995;610-617.
28. B. Castellano, Estudio histoquímico de la actividad TPPasa/NDPasa en neuronas y células gliales del sistema nervioso central, Doctoral Thesis, Autonomous University of Barcelona, 1987, 312 pp.
29. Chamak B., Mallat M. Fibronectin and laminin regulate the in vitro differentiation of microglial cells. Neuroscience. 45:1991;513-527.
30. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
31. Chen H., Cabon F., Sun P., Parmantier E., Dupouey P., Jacque C., Zalc B. Regional and developmental variations of GFAP and actin mRNA levels in the CNS of jimpy and shiverer mutant mice. J. Mol. Neurosci. 4:1993;89-96.
32. C.A. Colton, D.L. Gilbert, Microglia, an in vivo source of reactive oxygen species in the brain, in: F.J. Seil (Ed.), Advances in Neurology, Neural Injury and Regeneration, Vol. 59, Raven Press, New York, 1993, pp. 321-326.
33. Corbin J.G., Kelly D., Rath E.M., Baerwald K.D., Suzuki K., Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol. Cell. Neurosci. 7:1996;354-370.
34. Cotter T.G. Induction of apoptosis in cells of the immune system by cytotoxic stimuli. Semin. Immunol. 4:1992;399-405.
35. M.L. Cuzner, T. Smith, Immune responses in the central nervous system in inflammatory demyelinating disease, in: N.J. Rothwell (Ed.), Immune Responses in the Nervous System, Bios Scientific Publishers, Oxford, 1995, pp. 117-142.
36. Dautigny A., Mattei M.-G., Morello D., Alliel P.M., Pham-Dinh D., Amar L., Arnaud D., Simon D., Mattei J.-F., Guenet J.-L., Jollès P., Avner P. The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature. 321:1986;867-869.
37. de Groot C.J., Ruuls S.R., Theeuwes J.W., Dijkstra C.D., van der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:1997;10-20.
38. Delassalle A., Zalc B., Lachapelle F., Raoul M., Collier P., Jacque C. Regional distribution of myelin basic protein in the central nervous system of quaking, jimpy, and normal mice during development and aging. J. Neurosci. Res. 6:1981;303-313.
39. Dickinson P.J., Fanarraga M.L., Griffiths I.R., Barrie J.M., Kyriakides E., Montague P. Oligodendrocyte progenitors in the embryonic spinal cord express DM20. Neuropathol. Appl. Neurobiol. 22:1996;188-198.
40. Dijkstra C.D., Corline J.A., de Groot, Huitinga I. The role of macrophages in demyelination. J. Neuroimmunol. 40:1992;183-188.
41. Duncan I.D., Hammang J.P., Goda S., Quarles R.H. Myelination in the jimpy mouse in the absence of proteolipid protein. Glia. 2:1989;148-154.
42. I.D. Duncan, Inherited disorders of myelination of the central nervous system, in: H. Kettenmann, B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 990-1009.
43. Dupouey P., Lucas C.V., Gomes D., Jacque C. Immunohistochemical localization of the myelin basic protein and of the glial fibrillary acidic protein: comparative study in normal, quaking and jimpy mice. J. Neurosci. Res. 5:1980;387-398.
44. Dutly F., Schwab M.E. Neurons and astrocytes influence the development of purified O-2A progenitor cells. Glia. 4:1991;559-571.
45. D'Souza S.D., Alinauskas K.A., Antel J.P. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J. Neurosci. Res. 43:1996;289-298.
46. L.F. Eng, A.C.H. Yu, Y.L. Lee, Astrocytic response to injury, in: A.C.H. Yu, L. Hertz, M.D. Norenberg, E. Syková, S.G. Waxman (Eds.), Progress in Brain Research, Vol. 94, Elsevier, Amsterdam, 1992, pp. 353-365.
47. Fanarraga M.L., Dickinson P.J., Sommer I., Montague P., Kyriakides E., Griffiths I.R. Evidence that some oligodendrocyte progenitors in the developing optic pathway express the PLP gene. Glia. 18:1996;282-292.
48. Fanarraga M.L., Griffiths I.R., McCulloch M.C., Barrie J.A., Kennedy P.G., Brophy P.J. Rumpshaker - an X-linked mutation causing hypomyelination: developmental differences in myelination and glial cells between the optic nerve and spinal cord. Glia. 5:1992;161-170.
49. Fanarraga M.L., Sommer I.U., Griffiths I.R., Montague P., Groome N.P., Nave K.-A., Schneider A., Brophy P.J., Kennedy P.G. Oligodendrocyte development and differentiation in the rumpshaker mutation. Glia. 9:1993;146-156.
50. Fannon A.M., Moscarello M.A. Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse. Biochem. J. 268:1990;105-110.
51. Fannon A.M., Mastronardi F.G., Moscarello M.A. Isolation and identification of proteolipid proteins in jimpy mouse brain. Neurochem. Res. 19:1994;1005-1012.
52. Farkas-Bargeton E., Robain O., Mandel P. Abnormal glial maturation in the white matter in jimpy mice. An optical study. Acta Neuropathol. 21:1972;272-281.
53. Feutz A.-C., Bellomi I., Allinquant B., Schladenhaufen Y., Ghandour M.S. Isolation and characterization of defective jimpy oligodendrocytes in culture. J. Neurocytol. 24:1995;865-877.
54. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglia cells. Eur. J. Immunol. 17:1987;1271-1278.
55. msd mice. J. Neurochem. 51:1988;360-369.
56. msd mice. J. Neurosci. 10:1990;117-124.
57. Ghandour M.S., Skoff R.P. Expression of galactocerebroside in developing normal and jimpy oligodendrocytes in situ. J. Neurocytol. 17:1988;485-498.
58. Giulian D., Ingeman J.E. Colony-stimulating factors as promoters of ameboid microglia. J. Neurosci. 8:1988;4707-4717.
59. Giulian D., Allen R.L., Baker T.J., Tomozawa Y. Brain peptides and glial growth: I. Glia-promoting factors as regulators of gliogenesis in the developing and injured central nervous system. J. Cell Biol. 102:1986;803-811.
60. D. Giulian, The consequences of inflammation after injury to the central nervous system, in: S.K. Salzman, A.I. Faden (Eds.), The Neurobiology of Central Nervous System Trauma, Oxford Univ. Press, New York, 1994, pp. 155-164.
61. Gow A., Friedrich V.L. Jr., Lazzarini R.A. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37:1994;574-583.
62. Grell M., Zimmermann G., Hulser D., Pfizenmaier K., Scheurich P. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J. Immunol. 153:1994;1963-1972.
63. Griffiths I.R., Duncan I.D., McCulloch M., Harvey M.J. Shaking pups - a disorder of central myelination in the spaniel dog: Part 1. Clinical, genetic and light microscopical observations. J. Neurol. Sci. 50:1981;423-433.
64. Griffiths I.R., Scott I., McCulloch M.C., Barrie J.A., McPhilemy K., Cattanach B.M. Rumpshaker mouse - a new X-linked mutation affecting myelination: evidence for a defect in PLP expression. J. Neurocytol. 19:1990;273-283.
65. Griot C., Vandevelde M., Richard A., Peterhans E., Stocker R. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic. Res. Commun. 11:1990;181-193.
66. Hamilton S.P., Rome L.H. Stimulation of in vitro myelin synthesis by microglia. Glia. 11:1994;326-335.
67. Harding B., Ellis D., Malcolm S. A case of Pelizaeus-Merzbacher disease showing increased dosage of the proteolipid protein gene. Neuropathol. Appl. Neurobiol. 21:1995;111-115.
68. Hatfield J.S., Skoff R.P. GFAP immunoreactivity reveals astrogliosis in females heterozygous for jimpy. Brain Res. 250:1982;123-131.
69. Hauw J.J., Delaere P., Seilhean D., Cornu P. Morphology of demyelination in the human central nervous system. J. Neuroimmunol. 40:1992;139-152.
70. Hertz L., Chaban G., Hertz E. Abnormal metabolic response to excess potassium in astrocytes from the jimpy mouse, a convulsing neurological mutant. Brain Res. 181:1980;482-487.
71. Hirano A., Sax D.S., Zimmerman H.M. The fine structure of the cerebella of jimpy mice and their 'normal' litter mates. J. Neuropathol. Exp. Neurol. 28:1969;388-400.
72. Hodes M.E., Pratt V.M., Dlouhy S.R. Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci. 15:1993;383-394.
73. E.L. Hogan, S. Greenfield, Animal models of genetic disorders of myelin, in: P. Morell (Ed.), Mielin, 2nd edn., Plenum, New York, 1984, pp. 489-534.
74. L.D. Hudson, N.L. Nadon, Amino acid substitutions in proteolipid protein that cause dysmyelination, in: R.E. Martenson (Ed.), Myelin Biology and Chemistry, Telford Press, New Jersey, 1992, pp. 677-702.
75. Hudson L.D., Berndt J., Puckett C., Kozak C.A., Lazzarini R.A. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mouse. Proc. Natl. Acad. Sci. U.S.A. 84:1987;1454-1458.
76. Husain J., Juurlink B.H. Oligodendroglial precursor cell susceptibility to hypoxia is related to porr ability to cope with reactive oxygen species. Brain Res. 698:1995;86-94.
77. Ikenaka K., Kagawa T. Transgenic systems in studying myelin gene expression. Dev. Neurosci. 17:1995;127-136.
78. Ikenaka K., Furuichi T., Iwasaki Y., Moriguchi A., Okano H., Mikoshiba K. Myelin proteolipid protein gene structure and its regulation of expression in normal and jimpy mutant mice. J. Mol. Biol. 199:1988;587-596.
79. Ikenaka K., Kagawa T., Mikoshiba K. Selective expression of DM20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in non-glial cells. J. Neurochem. 58:1992;2248-2253.
80. Ikenaka K., Okano H., Tamura T., Mikoshiba K. Recent advances in studies on genes for myelin proteins. Dev. Growth Differ. 33:1991;181-192.
81. Imamoto K. Appearance of hematogeneous cells in the white matter of myelin-deficient jimpy mice. Arch. Histol. Jpn. 49:1986;297-307.
82. Inoue Y., Nakamura R., Mikoshiba K., Tsukada Y. Fine structure of the central myelin sheath in the myelin-deficient mutant shiverer mouse, with special reference to the pattern of myelin formation by oligodendroglia. Brain Res. 219:1981;85-94.
83. Jackson K.F., Duncan I.D. Cell kinetics and cell death in the optic nerve of the myelin-deficient rat. J. Neurocytol. 17:1988;657-670.
84. Jacque C., Delassalle A., Raoul M., Baumann N. Myelin basic protein deposition in the optic and sciatic nerves of dysmyelinating mutants quaking, jimpy, trembler, mld, and shiverer during development. J. Neurochem. 41:1983;1335-1340.
85. Jacque C., Lachapelle F., Collier P., Raoul M., Baumann N. Accumulation of GFAP, the monomeric precursor of the gliofilaments, during development in normal mice and dysmyelinating mutants. J. Neurosci. Res. 5:1980;379-385.
86. Jenkins H.G., Ikeda H. Tumor necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J. Neurol. Sci. 108:1992;99-104.
87. T.C. Jones, Hereditary disease, in: K. Beneyrechke, F.M. Garner, T.C. Jones (Eds.), Pathology of laboratory animals, Vol. II, Springer-Verlag, New York, 1972, pp. 1982-2048.
88. Kagawa T., Ikenaka K., Inoue Y., Kuriyama S., Tsujii T., Nakao J., Nakajima K., Aruga J., Okano H., Mikoshiba K. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron. 13:1994;427-442.
89. Kagawa T., Nakao J., Yamada M., Keiji S., Hayakawa T., Mikoshiba K., Ikenaka K. Fate of jimpy-type oligodendrocytes in jimpy heterozygote. J. Neurochem. 62:1994;1887-1893.
90. Kahn M.A., de Vellis J. Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia. 12:1994;87-98.
91. Keen P., Osborne R.H., Pehrson U.M.M. Respiration and metabolic compartmentation in brain slices from a glia-deficient mutant, the jimpy mouse. J. Physiol. 254:1976;22-23.
92. Kerner A.L., Carson J.H. Effect of the jimpy mutation on expression of myelin proteins in heterozygous and hemizygous mouse brain. J. Neurochem. 43:1984;1706-1715.
93. Kerner A.L., Carson J.H. Shiverer jimpy double mutant mice: I. Biochemical evidence for reciprocal intergenic suppression. Brain Res. 374:1986;45-53.
94. Kim Y.S., Kim S.U. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J. Neurosci. Res. 29:1991;100-106.
95. H.K. Kimelberg, M.D. Norenberg, Astrocytic responses to central nervous system trauma, in: S.K. Salzman, A.I. Faden (Eds.), The Neurobiology of Central Nervous System Trauma, Oxford Univ. Press, New York, 1994, pp. 193-208.
96. Klugmann M., Schwab M.H., Puhlhofer A., Schneider A., Zimmermann F., Griffiths I.R., Nave K.-A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron. 18:1997;59-70.
97. Knapp P.E., Skoff R.P. A defect in the cell cycle of neuroglia in the myelin-deficient jimpy mouse. Dev. Brain Res. 35:1987;301-306.
98. Knapp P.E., Skoff R.P. Jimpy mutation affects astrocytes: lengthening of the cell cycle in vitro. Dev. Neurosci. 15:1993;31-36.
99. Knapp P.E., Benjamins J.A., Skoff R.P. Epigenetic factors up-regulate expression of myelin proteins in the dysmyelinating jimpy mutant mouse. J. Neurobiol. 29:1996;138-150.
100. Knapp P.E., Booth C.S., Skoff R.P. The pH of jimpy glia is increased: intracellular measurements using fluorescent laser cytometry. Int. J. Dev. Neurosci. 11:1993;215-226.
101. Knapp P.E., Dutta S., Skoff R.P. Differences in levels of neuroglial cell death in jimpy male mice and carrier females. Dev. Neurosci. 12:1990;145-152.
102. Knapp P.E., Skoff R.P., Redstone D.W. Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit. J. Neurosci. 6:1986;2813-2822.
103. Koeppen A.H., Barron K.D., Csiza C.K., Greenfield E.A. Comparative immunocytochemistry of Pelizaeus-Merzbacher disease, the jimpy mouse, and the myelin-deficient rat. J. Neurol. Sci. 84:1988;315-327.
104. Kristt D.A., Butler F.K. Neuronal abnormalities associated with impaired myelination during brain development: a golgi study of neocortex in the jimpy mouse. Neurosci. Lett. 7:1978;107-113.
105. G. Labourdette, M. Sensenbrenner, Growth factors and their receptors in the central nervous system, in: H. Kettenmann, B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 441-459.
106. Lachapelle F., Gumpel M., Baumann N. Contribution of transplantations to the understanding of the role of the PLP gene. Neurochem. Res. 19:1994;1083-1090.
107. Lachapelle F., Lapie P., Campagnoni A.T., Gumpel M. Oligodendrocytes of the jimpy phenotype can be partially restored by environmental factors in vivo. J. Neurosci. Res. 29:1991;235-243.
108. Lachapelle F., Lapie P., Nussbaum J.L., Gumpel M. Immunohistochemical studies on cross-transplantations between jimpy, shiverer, and normal newborn mice. J. Neurosci. Res. 27:1990;324-331.
109. Lehrmann E., Kiefer R., Finsen B., Diemer N.H., Zimmer J., Hartung H.P. Cytokines in cerebral ischemia: expression of transforming growth factor beta-1 (TGF-1) mRNA in the postischemic adult rat hippocampus. Exp. Neurol. 131:1995;114-123.
110. C.E. Lewis, J.O'D. McGee, (Eds.), The Macrophage: the Natural Immune System, Oxford Univ. Press, New York, 1992, 423 pp.
111. Li X., Bartlett W.P. Developmental expression of glial fibrillary acidic protein and glutamine synthetase mRNAs in normal and jimpy mice. Mol. Brain Res. 9:1991;313-317.
112. Louis J.C., Magal E., Takayama S., Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 259:1993;689-692.
113. Macklin W.B., Gardinier M.V., King K.D., Kampf K. An AG-GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon. FEBS Lett. 223:1987;417-421.
114. msd mice. J. Neurochem. 56:1991;163-171.
115. McMorris F.A., McKinnon R.D. Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol. 6:1996;313-329.
116. Meier C., Bischoff A. Dysmyelination in 'jimpy' mouse. Electron microscopic study. J. Neuropathol. Exp. Neurol. 33:1974;343-353.
117. Meier C., Bischoff A. Oligodendroglial cell development in jimpy mice and controls. An electron-microscopic study in the optic nerve. J. Neurol. Sci. 26:1975;517-528.
118. Merrill J.E., Zimmerman R.P. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta. Glia. 4:1991;327-331.
119. Mikoshiba K., Okano H., Tamura T., Ikenaka K. Structure and function of myelin protein genes. Annu. Rev. Neurosci. 14:1991;201-217.
120. Mizuno T., Sawada M., Suzumura A., Marunouchi T. Expression of cytokines during glial differentiation. Brain Res. 656:1994;141-146.
121. Morello D., Dautigny A., Pham-Dinh D., Jolles P. Myelin proteolipid protein (PLP and DM20) transcripts are deleted in jimpy mutant mice. EMBO J. 5:1986;3489-3493.
122. Moriguchi A., Ikenaka K., Furuichi T., Okano H., Iwasaki Y., Mikoshiba K. The fifth exon of the myelin proteolipid protein-coding gene is not utilized in the brain of jimpy mutant mice. Gene. 55:1987;333-337.
123. Nadon N.L., Arnheiter H., Hudson L.D. A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J. Neurochem. 63:1994;822-833.
124. Nave K.-A., Bloom F.E., Milner R.J. A single nucleotide difference in the gene for myelin proteolipid protein defines the jimpy mutation in mouse. J. Neurochem. 49:1987;1873-1877.
125. Nave K.-A., Lai C., Bloom F.E., Milner R.J. Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9264-9268.
126. Nave K.-A. Neurological mouse mutants and the genes of myelin. J. Neurosci. Res. 38:1994;607-612.
127. K.-A. Nave, Neurological mouse mutants: a molecular-genetic analysis of myelin proteins, in: H. Kettenmann, B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 571-586.
128. Omlin F.X., Anders J.J. Abnormal cell relationships in jimpy mice: electron microscopic and immunocytochemical findings. J. Neurocytol. 12:1983;767-784.
129. Omlin F.X., Bischoff A., Moor H. Myelin and glial membrane structures in the optic nerve of normal and jimpy mouse. J. Neuropathol. Exp. Neurol. 39:1980;215-231.
130. Perry V.H., Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci. 11:1988;273-277.
131. Perry V.H., Gordon S. Macrophages and the nervous system. Int. Rev. Cytol. 125:1991;203-244.
132. Phillips R.J.S. Jimpy, a new totally sex-linked gene in the house mouse. Z. Vererbungsl. 86:1954;322-326.
133. C.M. Poser, Diseases of the myelin sheath, in: J.F. Minckler (Ed.), Pathology of the Nervous System, Vol. 1, McGraw-Hill, New York, 1968, pp. 767-820.
134. Privat A., Drian M.J., Escaig J. Jimpy mouse myelin revisited with freeze-fracture. Acta Neuropathol. 45:1979;129-131.
135. Privat A., Robain O., Mandel P. Aspects ultrastructuraux du corps calleux chez la souris jimpy. Acta Neuropathol. 21:1972;282-295.
136. Privat A., Valat J., Lachapelle F., Baumann N., Fulcrand J. Radioautographic evidence for the protracted proliferation of glial cells in the central nervous system of jimpy mice. Dev. Brain Res. 2:1982;411-416.
137. R.H. Quarles, P. Morell, D.E. McFarlin, Diseases involving myelin, in: G.J Siegel, B.W Agranoff, R.W. Albers, P.B. Molinoff (Eds.), Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 5th edn., Raven Press, New York, 1994, pp. 771-792.
138. C.S. Raine, The neuropathology of myelin diseases, in: P. Morell (Ed.), Mielin, 2nd edn., Plenum, New York, 1984, pp. 259-310.
139. Readhead C., Schneider A., Griffiths I., Nave K.-A. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron. 12:1994;583-595.
140. Robain O., Mandel P. Etude quantitative de la myélinisation et de la croissance axonale dans le corps calleux et le cordon postérieur de la moëlle chez la souris jimpy. Acta Neuropathol. 29:1974;293-309.
141. Rosenbluth J., Stoffel W., Schiff R. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 371:1996;336-344.
142. Rosenfeld J., Friedrich V.L. Jr. Hypomyelination and recovery of the myelin deficit in heterozygous jimpy mice. Int. J. Dev. Neurosci. 2:1984;21-32.
143. Roussel G., Neskovic N.M., Trifilieff E., Artault J.-C., Nussbaum J.-L. Arrest of proteolipid transport through the Golgi apparatus in jimpy brain. J. Neurocytol. 16:1987;195-204.
144. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 14:1993;325-337.
145. Sawada M., Suzumura A., Yamamoto H., Marunouchi T. Activation and proliferation of the isolated microglia by colony-stimulating factor-1 and possible involvement of protein kinase C. Brain Res. 509:1990;119-124.
146. Schneider A., Montague P., Griffiths I., Fanarraga M., Kennedy P., Brophy P., Nave K.-A. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature. 358:1992;758-760.
147. Schneider A.M., Griffiths I.R., Readhead C., Nave K.-A. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4447-4451.
148. Seitelberger F. Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol. 5:1995;267-273.
149. Selmaj K., Farooq M., Norton W.T., Raine C.S., Brosnan C.F. Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J. Immunol. 144:1990;129-135.
150. Selmaj K., Raine C.S., Farooq M., Norton W.T., Brosnan C.F. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
151. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
152. Shiota C., Ikenaka K., Mikoshiba K. Developmental expression of myelin protein genes in dysmyelinating mutant mice: analysis by nuclear run-off transcription assay, in situ hybridization, and immunohistochemistry. J. Neurochem. 56:1991;818-826.
153. Sidman R.L., Hayes R. Jimpy: a mouse with inherited sudanophilic leukodystrophy. J. Neuropathol. Exp. Neurol. 24:1965;172.
154. Sidman R.L., Dickie M.M., Appel S.H. Mutant mice (quaking and jimpy) with deficient myelination in central nervous system. Science. 144:1964;309-311.
155. R.P. Skoff, P.E. Knapp, What is the role of proteolipid protein in the biology of the normal and jimpy oligodendrocyte?, in: G. Levi (Ed.), Differentiation and Functions of Glial Cells, Wiley-Liss, New York, 1990, 307-316.
156. Skoff R.P., Montgomery I.N. Expression of mosaicism in females heterozygous for jimpy. Brain Res. 212:1981;175-181.
157. Skoff R.P. Increased proliferation of oligodendrocytes in the hypomyelinated mouse mutant-jimpy. Brain Res. 248:1982;19-31.
158. Skoff R.P. Myelin deficit in the jimpy mouse may be due to cellular abormalities in astroglia. Nature. 264:1976;560-562.
159. Skoff R.P. Programmed cell death in the dysmyelinating mutants. Brain Pathol. 5:1995;283-288.
160. Sorg B.A., Smith M.M., Campagnoni A.T. Developmental expression of the myelin proteolipid protein and basic protein mRNAs in normal and dysmyelinating mutant mice. J. Neurochem. 49:1987;1146-1154.
161. Sorg B.J., Agrawal D., Agrawal H.C., Campagnoni A.T. Expression of myelin proteolipid protein and basic protein in normal and dysmyelinating mutant mice. J. Neurochem. 46:1986;379-387.
162. Suzumura A., Sawada M., Yamamoto H., Marunouchi T. Effects of colony-stimulating factors on isolated microglia in vitro. J. Neuroimmunol. 30:1990;111-120.
163. Théry C., Hetier E., Evrard C., Mallat M. Expression of macrophage colony-stimulating factor gene in the mouse brain during development. J. Neurosci. Res. 26:1990;129-133.
164. Timsit S.G., Bally-Cuif L., Colman D.R., Zalc B. DM20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J. Neurochem. 58:1992;1172-1175.
165. Tosic M., Dolivo M., Amiguet P., Domanska-Janik K., Matthieu J.M. Paralytic tremor (pt) rabbit: a sex-linked mutation affecting proteolipid protein-gene expression. Brain Res. 625:1993;307-312.
166. Tosic M., Dolivo M., Domanska-Janik K., Matthieu J.M. Paralytic tremor (pt): a new allele of the proteolipid protein gene in rabbits. J. Neurochem. 63:1994;2210-2216.
167. U. Traugott, C.S. Raine, The neurology of myelin diseases, in: P. Morell (Ed.), Mielin, 2nd edn., Plenum, New York, 1984, pp. 311-335.
168. Ulrich J., Matthieu J.-M., Herschkowitz N., Kohler R., Heitz Ph.U. Immunocytochemical investigations of murine leukodystrophies. A study of the mutants 'jimpy' (jp) and 'myelin-deficient' (mld). Brain Res. 268:1983;267-274.
169. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:1995;732-743.
170. Vela J.M., Dalmau I., Acarín L., González B., Castellano B. Microglial cell reaction in the gray and white matter of the jimpy spinal cord. An enzyme histochemical study at the light and electron microscope level. Brain Res. 694:1995;287-298.
171. Vela J.M., Dalmau I., González B., Castellano B. Abnormal expression of PCNA in the spinal cord of the hypomyelinated jimpy mutant mice. Brain Res. 747:1997;130-139.
172. Vela J.M., Dalmau I., González B., Castellano B. The microglial reaction in spinal cords of jimpy mice is related to apoptotic oligodendrocytes. Brain Res. 712:1996;134-142.
173. Vela J.M., Hidalgo J., González B., Castellano B. Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mutant mouse. Brain Res. 767:1997;345-355.
174. Verity A.N., Levine M.S., Campagnoni A.T. Gene expression in the jimpy mutant: evidence for fewer oligodendrocytes expressing myelin protein genes and impaired translocation of myelin basic protein mRNA. Dev. Neurosci. 12:1990;359-372.
175. Vermeesch M.K., Knapp P.E., Skoff R.P., Studzinski D.M., Benjamins J.A. Death of individual oligodendrocytes in jimpy precedes expression of proteolipid protein. Dev. Neurosci. 12:1990;303-315.
176. Wolf M.K., Schwing G.B., Adcock L.H., Billings-Gagliardi S. Hypomyelinated mutant mice: III. Increased myelination in mutant cerebellum co-cultured with normal optic nerve. Brain Res. 206:1981;193-197.
177. Woodroofe M.N., Sarna G.S., Wadhwa M., Hayes G.M., Loughlin A.J., Tinker A., Cuzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33:1991;227-236.
178. Yanagisawa K., Quarles R.H. Jimpy mice: quantitation of myelin-associated glycoprotein and other proteins. J. Neurochem. 47:1986;322-325.
179. Yao J., Keri J.E., Taffs R.E., Colton C.A. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591:1992;88-93.
180. Yasuda T., Grinspan J., Stern J., Franceschini B., Bannerman P., Pleasure D. Apoptosis occurs in the oligodendroglial lineage, and is prevented by basic fibroblast growth factor. J. Neurosci. Res. 40:1995;306-317.